INTRODUCTION: CARD15 gene mutations may present different frequencies in populations and sometimes surgical interventions may become a necessary therapy for inflammatory bowel disease patients. Mutations of 1007fs, G908R, R702W and polymorphisms of P268S, IVS8+158 of the CARD15 gene and their relation with disease-related surgery were investigated in Turkish inflammatory bowel disease patients in this study. MATERIAL AND METHOD: 1007fs, G908R, R702W mutations and P268S, IVS8+158 polymorphisms of CARD15 gene were analyzed in 130 inflammatory bowel disease patients (67 Crohn's disease, 63 ulcerative colitis) and 87 healthy controls. After obtaining DNA samples, genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Results were evaluated by statistical analysis and accepted as significant if P < 0.05. RESULTS: R702W gene mutation was significantly lower in the inflammatory bowel disease group (1.5%) than the controls (4.8%) (P < 0.05). The overall allele frequency of mutations in the inflammatory bowel disease group (2.7%) was lower than in controls (6.6%) (P < 0.05). Disease-related surgery history was present in 20 Crohn's and 25 ulcerative colitis patients; familial history was present in four Crohn's and five ulcerative colitis patients. Statistically, no relationship was detected between disease-related surgeries and the investigated genetic tests. CONCLUSION: In Turkish patients, no important relationship was detected between the investigated allele frequencies of the CARD15 gene and inflammatory bowel disease nor between disease-related surgeries and inflammatory bowel disease.
INTRODUCTION:CARD15 gene mutations may present different frequencies in populations and sometimes surgical interventions may become a necessary therapy for inflammatory bowel diseasepatients. Mutations of 1007fs, G908R, R702W and polymorphisms of P268S, IVS8+158 of the CARD15 gene and their relation with disease-related surgery were investigated in Turkish inflammatory bowel diseasepatients in this study. MATERIAL AND METHOD: 1007fs, G908R, R702W mutations and P268S, IVS8+158 polymorphisms of CARD15 gene were analyzed in 130 inflammatory bowel diseasepatients (67 Crohn's disease, 63 ulcerative colitis) and 87 healthy controls. After obtaining DNA samples, genotyping was performed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) analysis. Results were evaluated by statistical analysis and accepted as significant if P < 0.05. RESULTS:R702W gene mutation was significantly lower in the inflammatory bowel disease group (1.5%) than the controls (4.8%) (P < 0.05). The overall allele frequency of mutations in the inflammatory bowel disease group (2.7%) was lower than in controls (6.6%) (P < 0.05). Disease-related surgery history was present in 20 Crohn's and 25 ulcerative colitispatients; familial history was present in four Crohn's and five ulcerative colitispatients. Statistically, no relationship was detected between disease-related surgeries and the investigated genetic tests. CONCLUSION: In Turkish patients, no important relationship was detected between the investigated allele frequencies of the CARD15 gene and inflammatory bowel disease nor between disease-related surgeries and inflammatory bowel disease.
Authors: Julia Seiderer; Stephan Brand; Karin A Herrmann; Fabian Schnitzler; Rudolf Hatz; Alexander Crispin; Simone Pfennig; Stefan O Schoenberg; Burkhard Göke; Peter Lohse; Thomas Ochsenkuhn Journal: Inflamm Bowel Dis Date: 2006-12 Impact factor: 5.325
Authors: T R Orchard; S Thiyagaraja; K I Welsh; B P Wordsworth; J S Hill Gaston; D P Jewell Journal: Gastroenterology Date: 2000-02 Impact factor: 22.682
Authors: J P Hugot; P Laurent-Puig; C Gower-Rousseau; J M Olson; J C Lee; L Beaugerie; I Naom; J L Dupas; A Van Gossum; M Orholm; C Bonaiti-Pellie; J Weissenbach; C G Mathew; J E Lennard-Jones; A Cortot; J F Colombel; G Thomas Journal: Nature Date: 1996-02-29 Impact factor: 49.962
Authors: M Barreiro; C Núñez; J E Domínguez-Muñoz; A Lorenzo; F Barreiro; J Potel; A S Peña Journal: Rev Esp Enferm Dig Date: 2005-08 Impact factor: 2.086
Authors: C Büning; J Genschel; S Bühner; S Krüger; K Kling; A Dignass; P Baier; B Bochow; J Ockenga; H H-J Schmidt; H Lochs Journal: Aliment Pharmacol Ther Date: 2004-05-15 Impact factor: 8.171
Authors: M Sugimura; Y Kinouchi; S Takahashi; H Aihara; S Takagi; K Negoro; N Obana; Y Kojima; K Matsumoto; T Kikuchi; M Hiroki; S Oomori; T Shimosegawa Journal: Clin Genet Date: 2003-02 Impact factor: 4.438
Authors: Peter J P Croucher; Silvia Mascheretti; Jochen Hampe; Klaus Huse; Henning Frenzel; Monika Stoll; Tim Lu; Susanna Nikolaus; Suk-Kyun Yang; Michael Krawczak; Won Ho Kim; Stefan Schreiber Journal: Eur J Hum Genet Date: 2003-01 Impact factor: 4.246
Authors: Sharyle A Fowler; Ashwin N Ananthakrishnan; Agnes Gardet; Christine R Stevens; Joshua R Korzenik; Bruce E Sands; Mark J Daly; Ramnik J Xavier; Vijay Yajnik Journal: J Crohns Colitis Date: 2014-01-24 Impact factor: 9.071